A share price of RenovoRx Inc [RNXT] is currently trading at $1.38, up 2.22%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The RNXT shares have gain 1.47% over the last week, with a monthly amount glided 11.29%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
RenovoRx Inc experienced fluctuations in its stock price throughout the past year between $0.75 and $1.69. RenovoRx Inc [NASDAQ: RNXT] shares were valued at $1.38 at the most recent close of the market.
Analyzing the RNXT fundamentals
Gross Profit Margin for this corporation currently stands at 0.61% with Operating Profit Margin at -48.35%, Pretax Profit Margin comes in at -42.33%, and Net Profit Margin reading is -42.33%. To continue investigating profitability, this company’s Return on Assets is posted at -0.63, Equity is -1.2 and Total Capital is -0.81. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.3425 points at the first support level, and at 1.3051 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.4087, and for the 2nd resistance point, it is at 1.4375.
Ratios To Look Out For
To put it in perspective, the Current Ratio for RenovoRx Inc [NASDAQ:RNXT] is 9.07. As well, the Quick Ratio is 9.07, while the Cash Ratio is 8.4. Considering the valuation of this stock, the price to sales ratio is 210.29, the price to book ratio is 3.83.
Transactions by insiders
Recent insider trading involved Agah Ramtin, Chief Medical Officer, that happened on Jun 05 ’25 when 21000.0 shares were purchased. Chief Medical Officer, Agah Ramtin completed a deal on Apr 15 ’25 to buy 15000.0 shares. Meanwhile, Chief Executive Officer Bagai Shaun bought 7500.0 shares on Apr 15 ’25.
